Bring your next strain development project to market faster. Our proprietary CRISPR technologies enable precise genome editing and targeted cell depletion across diverse organisms, helping you streamline development and accelerate innovation.
Reducing development time and complexity
Whether you are working with bacteria, yeast, fungi, plants, or animal cells, our patented nucleases can help you achieve precise genetic modifications or targeted cell depletion while reducing development time and complexity.
Overcoming challenging bottlenecks in microbial strain development
Do you need a solution tailored to a specific microorganism? Benefit from our more than 30 years of experience in microbiology and genetic engineering. We help to overcome challenging bottlenecks in microbial strain development, from standard bacteria to non-conventional yeasts and fungi.
CRISPR-BMC
Precise genome editing across diverse organisms
Gain easy access to our proprietary CRISPR-BMC technology and expand your genome editing capabilities with licensed access to our patented technology.
BMC® (BRAIN Metagenome Cas) nucleases are metagenomic enzymes available for multiple classes of microorganisms, as well as for plant and animal cell lines. This technology is protected by a granted European substance patent (EP 4 301 852), which provides legal certainty for commercial applications.
Unlock new counter-selection possibilities with BEC®
BEC® technology can support applications such as:
- Depleting phage- or virus-infected cells during bioprocessing
- Eliminating pest-infested plant seedlings
- Accelerating the modification of difficult-to-engineer microorganisms
Commercial users can license our patented BEC® technology (EP 4 025 691) through flexible licensing agreements.
Ask about our flexible and clear licensing conditions for BEC® nucleases
